Global Gateway Advisors - Communicate Across Borders

Knowledge.
Forums.
People.

At @92Y for a discussion w/ @CoryBooker and @RockefellerFdn President Judith Rodin on how #cities are leading us out of the great #recession
- Monday Jun 17 - 11:15pm

Top 30 social entrepreneurship reads for aspiring changemakers via @Ashoka http://t.co/i5GyBNbjrK #bestread #socent
- Thursday Jun 13 - 8:09pm

A new class of drugs is being developed in the struggle against cancer via @TheEconomist http://t.co/8SRH1tLuxX #immunotherapy
- Friday Jun 7 - 3:39pm

#Immunotherapy Cancer Drug Race Speeds Up After Medical Meeting #ASCO13 via @WSJ http://t.co/aNa2rEp8O0
- Friday Jun 7 - 3:38pm

Alan Kandel: #Ideas that fall under rubric of #SmartGrowth benefit ALL of us http://t.co/N8AsvtmEiQ
- Sunday Jun 2 - 4:57pm

.@MelindaGates: #Women empower themselves. But there are things we can do to help via @FastCoExist http://t.co/yQF9RsOiHk
- Sunday Jun 2 - 12:55pm

Are Social Impact Bonds the future of international development? via @fastcoexist http://t.co/b1CXbDK5eJ #SocInn #SocEn
- Saturday Jun 1 - 9:05pm

In 10 years #immunotherapy will be treating 60% of cancers & earning US$35B a year via @NatureMagazine http://t.co/BbZVfQ90F4
- Saturday Jun 1 - 7:57pm

In-pharmaTechnologist.com: New DFS Unit Built on Technology, R&D and Manufacturing, says Capsugel

2013-05-22 16:00:59

Following a busy few months, Capsugel spoke about the formation of its Dosage Form Solutions Unit, its technology and the integration of Encap at this year’s Interphex in New York. According to Aresh Tahbez, the Director of Global Marketing at Capsugel’s recently formed Dosage Forms Solutions (DFS) Unit, the Unit is built upon three areas: Capsugel’s technologies, its R&D capabilities and its manufacturing infrastructure.

Bloomberg Businessweek: Fed’s Rosengren Says Small City Collaboration is Crucial

2013-05-03 10:20:30

Federal Reserve Bank of Boston President Eric Rosengren said regional collaboration between cities and government agencies is a “crucial factor” in strengthening the economies of smaller cities. “We need more public-private cooperation, collaboration, and investment aimed at removing the barriers that are holding back our smaller and medium sized cities,” Ben Hecht, president of Living Cities Inc., a philanthropic organization that is also helping to fund the initiative, said in the statement today.

News-Medical: An interview with Dr. Paul Mischel, Ludwig Institute for Cancer Research

2013-04-09 06:43:42

Can you give a brief introduction to the mammalian target of rapamycin (mTOR) pathway? The mammalian target of rapamycin, mTOR is a central integrator of the cell that coordinates growth factor receptor signaling with energy and nutrient status to control a wide array of activities, including the regulation of cellular proliferation and survival. Thus, mTOR has emerged as a compelling cancer drug target, particularly for glioblastoma, the most common and lethal form of adult brain cancer.